Cancer care is a demanding yet rapidly evolving field, and it’s crucial for healthcare professionals, organizations and patients to have access to clear policies. touchONCOLOGY supports individuals, organizations and societies that advocate for impactful policy changes by fostering collaboration and consensus within the oncology community on key issues in cancer care. In partnership with the European Cancer Organisation, touchONCOLOGY has developed video content and brief articles to highlight important policy challenges in the field.
Our supporting partners do not constitute an endorsement of the content on this page.
In this Future Leaders interview, Dr Gyawali discusses how patient-centered care, evidence-based practice and mentorship have shaped his career, and why curiosity, resilience and purpose are essential for the next generation of oncologists.
In this Future Leaders interview, Dr Soniya Dulal discusses the global mentors who shaped her career, the importance of building sustainable oncology systems in Nepal and how precision medicine, palliative care and international collaboration can improve patient outcomes in resource-limited settings.
The newly released Lancet Commission on hepatocellular carcinoma (HCC) is a powerful wake-up call to the global health community. It highlights that more than 60% of liver cancer cases are preventable through action on hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol use. Without intervention, HCC cases could double by 2050 – reaching over 1.5 million new cases annually and 1.37 million deaths.
In this interview, we are joined by President-Elect of the European Cancer Organisation (ECO), Dr Isabel Teresa Rubio (Head of Breast Surgical Oncology at Clínica Universidad de Navarra, Professor of Surgery at the University of Navarra, Spain). She discusses ...
7 January 2025, Brussels - The European Cancer Organisation (ECO) is pleased to announce the appointment of Elisabetta Zanon as its new Chief Executive Officer, effective 3 February. Elisabetta is a senior professional with more than 20 years of experience in European affairs, much ...
Precision medicine aims to tailor medical treatments to individual patients based on their characteristics and genetic makeup. Phase I clinical trials are seeing changes in their objectives and designs in the era of precision medicine. In this touchONCOLOGY interview, we ...
The European Society of Surgical Oncology (ESSO), along with other cancer-related European societies, supported the proposal for cross-multidisciplinary training in oncology at the EU level. It was a pleasure to talk with Prof. Pompiliu Piso (Hospital Barmherzige Brueder, Regensburg, Germany) ...
The European Society of Surgical Oncology (ESSO) recently released an open letter urging the European Commission to recognise surgical oncology as a specialist discipline in the EU, entitled 'Time to act: Maximizing the benefits of surgical oncology for cancer patients ...
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.